| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 69.722 | 69.845 | 63.718 | 54.958 | 41.286 | 45.832 | 41.768 | 44.047 | 39.507 | 30.410 |
| Total Income - EUR | 69.722 | 69.845 | 63.718 | 54.958 | 41.286 | 45.832 | 41.768 | 44.047 | 39.507 | 52.382 |
| Total Expenses - EUR | 67.219 | 69.617 | 63.401 | 54.231 | 46.661 | 50.821 | 63.241 | 42.979 | 47.868 | 51.815 |
| Gross Profit/Loss - EUR | 2.503 | 228 | 317 | 728 | -5.375 | -4.988 | -21.473 | 1.068 | -8.361 | 568 |
| Net Profit/Loss - EUR | 2.503 | 228 | 317 | 178 | -5.815 | -5.447 | -21.891 | 648 | -8.756 | 201 |
| Employees | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 2 |
Check the financial reports for the company - Irifarm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 17.431 | 12.287 | 12.079 | 11.858 | 11.628 | 11.408 | 11.155 | 11.189 | 11.155 | 0 |
| Current Assets | 25.348 | 22.035 | 18.890 | 20.296 | 26.184 | 36.804 | 51.233 | 72.687 | 73.915 | 40 |
| Inventories | 20.858 | 18.268 | 16.318 | 17.277 | 23.378 | 33.973 | 47.040 | 68.052 | 69.368 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 117 | 196 | 1.652 | 2.092 | 1.946 | 0 |
| Cash | 4.489 | 3.767 | 2.572 | 3.019 | 2.688 | 2.635 | 2.541 | 2.543 | 2.600 | 40 |
| Shareholders Funds | -901 | -663 | -335 | -151 | -5.963 | -11.297 | -32.937 | -32.391 | -41.049 | 40 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 43.679 | 34.986 | 31.304 | 32.304 | 43.775 | 59.509 | 95.324 | 116.268 | 126.119 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Irifarm Srl